The Keck School of Medicine of USC has received $2 million from the California Institute of Regenerative Medicine (CIRM) to further augment its newly launched cGMP Laboratory, a state-of-the-art facility designed to advance early-stage research into clinically viable cell and gene therapies.
Pfizer gene therapy gets hemophilia B approval in Canada, setting stage for CSL rivalry
Pfizer has secured an approval for its gene therapy for hemophilia B in Canada, months ahead of an expected decision in the US. The approval
January 4, 2024